We're supporting a leading, global biopharma organisation in appointing an Evidence Synthesis Manager to drive the development of high-quality payer evidence and value materials supporting global market access strategy.
This role sits within a global HTA & Payer function and offers strong exposure to asset strategy, cross-functional collaboration, and global-local market access activities. You will be expected to work autonomously and within a small team with a tight-knit culture, so personality-fit is very important.
Key Responsibilities
* Lead development and delivery of core payer evidence deliverables (e.g. Global Value Dossiers, value narratives, assessment reports)
* Translate payer strategy into clear, decision-ready materials aligned to global access plans (MASS)
* Identify evidence gaps and collaborate with HEOR/RWE teams to inform evidence generation
* Support asset strategy discussions with evidence-based insights
* Enable regional/local teams with globally aligned value tools and messaging
* Manage external partners and contribute to scientific communications
The ideal candidate will have:
* Experience in market access, HTA, HEOR, or payer evidence (industry or consulting)
* Track record supporting global or asset-level access/evidence projects
* Strong understanding of payer/HTA environments (major markets preferred)
* Excellent stakeholder engagement and scientific communication skills
* Excellent time-management, problem-solving and interpersonal skills
If this sound like the role for you then apply now!
Keywords: Evidence Synthesis Manager, market access, Evidence synthesis, Health economics, Commercial strategy, buyer, HTA, Payer evidence, HEOR, Pharmaceutical, indications, rare disease, immunology, economics, London, Manchester, Birmingham, Liverpool, Leeds, Oxford, Cambridge VRS9395DT
#J-18808-Ljbffr